1. Alexander, G. J., Medve, M., and Chatterjie, N. 1987. Opiate agonist/antagonist activity of 6-spirohydantoin derivatives of oxymorphone, oxycodone, naloxone and naltrexone. Federation Proc. 46:2036.
2. Chatterjie, N., and Alexander, G. J. 1984. Anticonvulsive spirohydantoin derivatives of opiate antagonists. IRCS Med. Sci. 12:340–341.
3. Portoghese, P. S., Larson, D. L., and Jiang, J. B. 1979. Synthesis and pharmacologic characterization of an alkylating analogue (chlornaltrexamine) of naltrexone with ultralong-lasting narcotic antagonist properties. J. Med. Chem. 22:168–173.
4. Caruso, T. P., Larson, D. L., Portoghese, P. S., and Takemori, A. E. 1980. Pharmacological studies with an alkylating narcotic agonist, chloroxymorphamine, and antagonist, chlornaltrexamine. J. Pharmacol. Exper. Therap. 213:539–544.
5. Ko, R. P., Gupte, S. M., and Nelson, W. L. 1984. Opioid agonists and antagonists, 6,6-Hydrazi- and 6-oximino derivatives of 14-hydroxy-dihydromorphinones. J. Med. Chem. 27:1727–1729.